Work

MA07.02 Evaluating Circulating Tumor DNA to Predict Overall Survival Risk in Non-Squamous Non-Small Cell Lung Cancer in IMpower150

Year: 2021

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2021.08.141

Authors: Z.J. Assaf, A. Fine, W. Zou, M. Socinski, A. Young, J. Freidin, M. Kennedy, E. Polisecki, M. Nishio, G. Oxnard, C. Cummings, A. Rode, M. Reck, N. Patil, D. Shames, K. Schulz

Institutions: Genentech, Foundation Medicine (United States), AdventHealth, The Cancer Institute Hospital, Japanese Foundation For Cancer Research, German Center for Lung Research, LungenClinic Grosshansdorf

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3207211483

Cites:

Cited by: 3

Related to: 10